Google Partners with DexCom to Create a Miniature Glucose Monitor


A drop of blood. A strip and a meter that reads the blood glucose levels. That is the normal routine for so many in the United States. 10% of Americans, that is 21.9 million people, have diabetes....

Testosterone Treatment Provides Cardiovascular Benefits to Veterans


Testosterone Replacement Therapy (TRT) has a salubrious effect on older males. That is if they suffered from cardiovascular difficulties, myocardial infarction or stroke. They will benefit via TRT....

Two Generic and Inexpensive Drugs Can Reduce Breast Cancer Deaths


Studies published in "The Lancet" claim that two inexpensive and generic drugs can significantly reduce the recurrence of breast cancer in postmenopausal women and can decrease the death rate.The...

High Hormone Levels Make Traders Take More Risk


A new study shows that hormones testosterone and cortisol may destabilize financial markets by making traders take more risks. The researchers simulated the trading floor in the lab by having...

Apple Watch App monitors Glucose Levels for Diabetics


DexCom has built an app that can work in conjunction with an Apple Watch and show glucose readings of diabetics thereby saving the day for those afflicted with the disease. This of course lends the...

Women with Type 1 diabetes at greater risk of death than men


Bad news for women with Type 1 diabetes. A recent study by the University of Queensland's School of Public Health shows that women with Type 1 diabetes have a 40 percent higher risk of death than men...

African American women working night shift at risk for Type 2 diabetes


Diabetes is serious illness for many Americans. The CDC estimates that 1 in 11 people have either Type 1 or Type 2 and 1 in 4 are entirely unaware. Studies show that 1 in 3 million people, or 86...

Diabetics Rejoice: MannKind’s Insulin Inhaler Afrezza’s FDA-Approved


MannKind's inhaler insulin Afrezza gained F.D.A. approval, Friday, June 27. Andrew Pollack of the New York Times offers a lot of good news for insulin-dependent diabetics in "Afrezza, a New...